Ajax Therapeutics is a biotechnology company developing therapies to target cytokine signaling pathways that drive hematologic malignancies.
Ajax Therapeutics is an NYC-based biotechnology company applying computational chemistry and structure-based technologies to develop novel small molecules for hematologic malignancies
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 1, 2021 | Series Unknown | $40M | 2 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Schrödinger | — | Series Unknown |
Inning One Ventures | — | Series Unknown |